US now armed with data on harm from China’s biotech blocks

China’s opaque and deliberately slow biotech approval process is costing U.S. farmers, exporters, seed companies and others billions of dollars in lost sales, according to a new analysis being released today by Informa’s Agribusiness Consulting.